Cargando…
Therapeutic metastatic prostate cancer vaccines: lessons learnt from urologic oncology
INTRODUCTION: Therapeutic cancer vaccines have been recognized as a promising treatment option in clinical oncology for nearly three decades. However, despite many efforts, only one cancer vaccine – sipuleucel-T, activating the anti-PAP (prostatic acid phosphatase) immune response, has obtained Food...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Polish Urological Association
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8552937/ https://www.ncbi.nlm.nih.gov/pubmed/34729217 http://dx.doi.org/10.5173/ceju.2021.0094 |